✦ LIBER ✦

The “A, B and C” of Her-2 DNA vaccine development

✍ Scribed by Wei-Zen Wei; Jennifer Jacob; Olga Radkevich-Brown; Paula Whittington; Yi-chi M. Kong

Publisher: Springer-Verlag
Year: 2008
Tongue: English
Weight: 334 KB
Volume: 57
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-008-0464-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Her-2 DNA versus cell vaccine: immunogen

Her-2 DNA versus cell vaccine: immunogenicity and anti-tumor activity

✍ Paula J. Whittington; Olga Radkevich-Brown; Jennifer B. Jacob; Richard F. Jones; 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 456 KB

The development of a multivalent DNA vac

The development of a multivalent DNA vaccine for malaria

✍ Hedstrom, Richard C. ;Doolan, Denise L. ;Wang, Ruobing ;Gardner, Malcolm J. ;Kum 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 988 KB

Promoting effect ofAntrodia camphorataas

Promoting effect ofAntrodia camphorataas an immunomodulating adjuvant on the antitumor efficacy of HER-2/neu DNA vaccine

✍ Chia-Hsin Huang; Chia-Che Chang; Chiu-Mei Lin; Sin-Ting Wang; Min-Tze Wu; Eric I 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 672 KB

Detection of HER-2/neu (c-erb B-2) DNA a

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma : Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression

✍ Hitoshi Tsuda; Futoshi Akiyama; Hiroshi Terasaki; Tadashi Hasegawa; Masafumi Kur 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 593 KB

In vivo electroporation restores the low

In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in aging

✍ Mauro Provinciali; Alessandra Barucca; Elisa Pierpaoli; Fiorenza Orlando; Sara P 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 388 KB

Characterization of a human monoclonal a

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine

✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs